Detecting Chromosomal Abnormalities in Blood Disorders
Author Information
Author(s): Gondek Lukasz P., Dunbar Andrew J., Szpurka Hadrian, McDevitt Michael A., Maciejewski Jaroslaw P.
Primary Institution: Cleveland Clinic, Cleveland, Ohio, United States of America
Hypothesis
If cytogenetic methods with a higher resolution are used, additional defects, including UPD of chromosomal regions other than 9p, will be detected.
Conclusion
SNP-A can effectively identify cryptic chromosomal abnormalities in patients with MDS/MPD-U and secondary AML.
Supporting Evidence
- SNP-A detected UPD9p in patients with the JAK2 V617F mutation.
- Additional chromosomal lesions were found in 19 out of 30 MDS/MPD-U patients.
- SNP-A revealed cryptic abnormalities not identified by conventional cytogenetics.
Takeaway
This study used a special test to find hidden problems in the DNA of patients with blood disorders, helping doctors understand their diseases better.
Methodology
The study applied 250K SNP arrays to examine genomic composition and identify chromosomal defects in patients with MDS/MPD-U and secondary AML.
Limitations
SNP-A cannot detect balanced translocations and may miss small clones if tumor content is low.
Participant Demographics
Patients included 30 with MDS/MPD-U and 8 with MPD, mean age 69 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website